Top

Published in:

01-06-2015 | Original Contributions

Perceptions of Weight, Diabetes and Willingness to Participate in Randomised Controlled Trials of Bariatric Surgery for Patients With Type 2 Diabetes Mellitus and Body Mass Index 30–39.9 kg/m²

Authors: Rachael H. Summers, Michael Moore, James Byrne, Christopher Byrne, Mark Mullee, Richard Welbourn, Helen Elsey, Paul Roderick

Published in: Obesity Surgery | Issue 6/2015

Abstract

Purpose

Evidence from high-quality randomised controlled trials (RCTs) is needed to establish the long-term benefit of bariatric surgery in people with type 2 diabetes mellitus (T2DM) and body mass index (BMI) 30–39.9 kg/m². However, willingness amongst this group to be randomised and undergo surgery is uncertain. This study assessed UK patients’ perceptions of their weight and diabetes, and associations with willingness to participate in RCTs involving bariatric surgery, amongst this population.

Materials and Methods

Postal survey of 1820 patients from four regions in England. Eligible patients were as follows: BMI 30–39.9 kg/m², 18–74 years, diagnosis of T2DM ≥2 years. A reminder survey was sent after 4 weeks. Independent predictors influencing patients’ willingness to consider RCT participation were identified using multiple logistic regression analysis.

Results

Thirty-four per cent (614/1820) of patients responded. Weight was considered to be harder to control than diabetes [468/584 (80 %) vs. 107/600 (17 %)]. More people reported a negative impact on life for weight rather than diabetes [379/579 (63 %) vs. 180/574 (31 %)]. Feeling unsatisfied/very unsatisfied with weight loss ability was common 261/578 (45 %). Sixty-four per cent (379/594, CI = 60–68) were willing to consider participating in an RCT. In multivariate analysis, negative impact of weight on life (OR = 2.55, 95 % CI = 1.68–3.89, P < 0.001) and feeling unsatisfied with weight loss ability (OR = 2.47, 95 % CI = 1.55–3.95, P < 0.001) positively influenced patients’ willingness to participate in an RCT.

Conclusion

Strong patient interest supports the feasibility of such trials for this group. Perceptions of obesity negatively impacting on life and difficulties in achieving weight loss were common and influenced attitudes to potential participation in bariatric surgery RCTs.

Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv.CrossRef

Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. Am J Med. 2009;122(3):248–U81.CrossRefPubMed

Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New Engl J Med. 2012;367(8):695–704.CrossRefPubMed

Welbourn R, Fiennes A, Kinsman R, et al. The National Bariatric Surgery Registry: First Registry Report to March 2010. Dendrite Clinical Systems Ltd: Henley-on-Thames; 2010.

Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 2013-10-22 23:31:18;347

Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med:J Br Diabet Assoc. 2011;28(6):628–42.CrossRef

Norris SL, Zhang X, Avenell A, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. The Cochrane database of systematic reviews. 2005 (2):CD004095. PubMed PMID: 15846698

O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program - A randomized trial. Ann Intern Med. 2006;144(9):625–33.CrossRefPubMed

Courcoulas AP, Goodpaster BH, Eagleton J, et al. Surgical vs medical treatments for type 2 diabetes mellitus: A randomized clinical trial. JAMA Surg. 2014;149(7):707–15.CrossRefPubMed

10.

Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial. JAMA J Am Med Assoc. 2008;299(3):316–23.CrossRef

11.

Lee W-J, Chong K, Chen C-Y, et al. Diabetes Remission and Insulin Secretion After Gastric Bypass in Patients with Body Mass Index <35 kg/m2. Obes Surg. 2011;21(7):889–95. English.CrossRefPubMed

12.

Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabet Obes Metab. 2012;14(3):262–70.CrossRef

13.

Schauer PR, Kashyap SR, Wolski K, et al. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med. 2012;366(17):1567–76.CrossRefPubMedCentralPubMed

14.

Fletcher B, Gheorghe A, Moore D, et al. Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. Bmj Open. 2012;2 (1)

15.

McDonald AM, Knight RC, Campbell MK, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006 Apr 7;7

16.

Toerien M, Brookes ST, Metcalfe C, et al. A review of reporting of participant recruitment and retention in RCTs in six major journals. Trials. 2009;10:52.CrossRefPubMedCentralPubMed

17.

Sarwer DB, Ritter S, Wadden TA, et al. Attitudes about the safety and efficacy of bariatric surgery among patients with type 2 diabetes and a body mass index of 30–40 kg/m2. Surg Obes Relat Dis. 2013;9(5):630–5.CrossRefPubMed

18.

Summers RH, Elsey H, Moore M, et al. Weight loss surgery for non-morbidly obese populations with type 2 diabetes: is this an acceptable option for patients? Prim Health Care Res Dev. 2013;5:1–10.

19.

World Health Organisation Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.CrossRef

20.

Government DfCaL. The English Indices of Deprivation is a measure of multiple deprivation at the small area level. Department for Communities and Local Government, 2011. Available from: http://webarchive.nationalarchives.gov.uk/20120919132719/http://www.communities.gov.uk/publications/corporate/statistics/indices2010

21.

Karmali S, Kadikoy H, Brandt ML, et al. What is my goal? Expected weight loss and comorbidity outcomes among bariatric surgery patients. Obes Surg. 2011;21(5):595–603.CrossRefPubMed

22.

Ogden J, Clementi C, Aylwin S. The impact of obesity surgery and the paradox of control: A qualitative study. Psychol Health. 2006;21(2):273–93.CrossRefPubMed

23.

World Health Organization. Diabetes, Fact sheet No 312. 2012 23/10/2012. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/index.html

24.

Woodcock A, Kinmonth AL. Patient concerns in their first year with Type 2 diabetes: Patient and practice nurse views. Patient Educ Couns. 2001;42:257–70.CrossRefPubMed

25.

Lawton J, Ahmad N, Hanna L, et al. ‘I can’t do any serious exercise’: barriers to physical activity amongst people of Pakistani and Indian origin with Type 2 diabetes. Health Educ Res. 2006;21(1):43–54.CrossRefPubMed

26.

Nair KM, Levine MAH, Lohfield LH, et al. “I take what I think works for me”: a qualitative study to explore patient perception of diabetes treatment benefits and risks. Can J Clin Pharmacol. 2007;14(2):251–9.

27.

Moser A, Van Der Bruggen H, Spreeuwenberg C, et al. Autonomy through identification: a qualitative study of the process of identification used by people with type 2 diabetes. J Clin Nurs. 2008;17(7B):209–16.CrossRefPubMed

28.

Murphy E, Kinmonth AL. No symptoms, no problem? Patients’ understandings of non-insulin dependent diabetes. Fam Pract. 1995;12(2):184–92.CrossRefPubMed

29.

Groves RM. Nonresponse rates and nonresponse bias in household surveys. Public Opin Q. 2006;70(5):646–75.CrossRef

Title: Perceptions of Weight, Diabetes and Willingness to Participate in Randomised Controlled Trials of Bariatric Surgery for Patients With Type 2 Diabetes Mellitus and Body Mass Index 30–39.9 kg/m2
Authors: Rachael H. Summers
Michael Moore
James Byrne
Christopher Byrne
Mark Mullee
Richard Welbourn
Helen Elsey
Paul Roderick
Publication date: 01-06-2015
Publisher: Springer US
Published in: Obesity Surgery / Issue 6/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-014-1479-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Perceptions of Weight, Diabetes and Willingness to Participate in Randomised Controlled Trials of Bariatric Surgery for Patients With Type 2 Diabetes Mellitus and Body Mass Index 30–39.9 kg/m²

Abstract

Purpose

Materials and Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2015

Bariatric Surgery Operating Room Time—Size Matters

Laparoscopic and Robotic Sleeve Gastrectomy: Short- and Long-Term Results

Does Bariatric Surgery Influence Diabetic Retinopathy?

Impact of Bariatric Surgery on the Medical Management and Costs of Obese Patients in France: an Analysis of a National Representative Claims Database

Prevalence of Anemia and Related Deficiencies 10 Years After Gastric Bypass—a Retrospective Study

Short-Term Pilot Study of the Effect of Sleeve Gastrectomy on Food Preference